Back to BBIO

Aisling Capital Management LP → BBIO

Aisling Capital Management LP BBIO Position History

BridgeBio Pharma, Inc. • Healthcare

Quarters held
4
Latest value
$203.3M
Q3 2026
Peak value
$389.3M
First seen
Q4 2025

Dollar value over time

Show data table
PeriodPosition value
Q4 2025$389.3M
Q1 2026$378M
Q2 2026$341.8M
Q3 2026$203.3M

Quarter-by-quarter history

Every disclosed snapshot of the position

QuarterValueShares% PortfolioChange
Q3 2026$203.3M3.09M——
Q2 2026$341.8M4.59M——
Q1 2026$378M5.09M——
Q4 2025$389.3M5.09M——

Other funds holding BBIO

Other Aisling Capital Management LP positions

MNST

MONTE ROSA THERAPEUTICS INC

$37.6M
SNDX

Syndax Pharmaceuticals, Inc. (SNDX)

$30.8M
SNDX

SYNDAX PHARMACEUTICALS INC

$28.8M
SNDX

Syndax Pharmaceuticals, Inc. (SNDX)

$27.7M
MNST

Monte Rosa Therapeutics Inc (GLUE)

$25.6M
SNDX

SYNDAX PHARMACEUTICALS INC

$24.8M
MNST

Monte Rosa Therapeutics Inc (GLUE)

$23.1M
CMPS

COMPASS PATHWAYS PLC

$21.6M